| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |